Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals Inc has faced significant challenges in its financial performance, highlighted by a sharp decline in revenue growth, which fell to -32.98% in Q3 2025 from +30.14% in Q2 2025.

This mission is initiated by speaking to a purple multi-legged monster carrying a box on the MU campus. The monster asks if the character will them recover some tokens they lost. Follow the arrows ...

You can also throw down a JUMP PAD that, when stepped on, takes you to your most recent Backtracker. The backtrack has a 15 second warm-up. The Backtracker has an active state when placed and looks ...

Step right up, New York Jets fans, and meet the many faces (and answers) of head coach Aaron Glenn! Upset after a blowout win? The coach will give a rah-rah response to make you feel like he’s just as ...